Clinical Trials Logo

Clinical Trial Summary

Insect bite related symptoms (pruritus and papules) are caused by the release of histamine by mast cells in the skin. Topical anti-histaminics can be used to promote relief of these symptoms. Dexchlorpheniramine maleate 1% cream is a topical anti-histaminic formulation approved by ANVISA in Brazil for the relief of skin irritation and allergies, including the ones caused by insect bites. The aim of the present study is to demonstrate non-inferiority of a new pharmacological preparation of dexchlorpheniramine maleate (1% lotion) with the standard preparation (1% cream) for the relief of insect bite related symptoms and to demonstrate the safety of both preparations.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00995397
Study type Interventional
Source Mantecorp Industria Quimica e Farmaceutica Ltd.
Contact Sérgio Schalka, MD
Phone +551136811334
Status Unknown status
Phase Phase 3

See also
  Status Clinical Trial Phase
Completed NCT03999970 - A Clinical Study to Develop an Uninfected Sand Fly Biting Protocol N/A
Completed NCT04512742 - A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies N/A
Active, not recruiting NCT00825214 - Evaluation of Zapperclick Device for Relief From Mosquito Bites Phase 3
Not yet recruiting NCT01233934 - Comparative Study of Two Forms of Topical Dexchlorpheniramine Maleate (Cream Versus Gel) for Insect Bites Phase 3
Terminated NCT03619746 - Point-of-Care Ultrasound Educational Initiative for Insect Bites N/A